Gong Ping

2015.1~ 2006.8～2014.12, 2000.9～2006.6 1992.9～2000.8 、 、 (2002 ): (1)《 》(2004, ); (2)《 、 》(2003, ); (3)《3-NPA 》(2005, ); (4)《 》(2004,, 04-07SF047); (5)《VEGF 》(2003,, 0305364); (6)《 》(2009 ) (7)《 》(2011 GF,, PKU-PY2011-003); (8)《 》(2020,, 81973130) 《 “ ” 》: 1. Yao SS, Cao GY, Han L, Chen ZS, Huang ZT, Gong P, Hu Y, Xu B. Prevalence and patterns of multimorbidity in a nationally representative sample of older Chinese: results from CHARLS. J Gerontol A Biol Sci Med Sci. 2019 Aug 13. doi:10.1093/gerona/glz185. 2. Gongping,Zhangwei,Dengfang,etal.Tectorigenin attenuates the MPP+-induced SH-SY5Y cell damage, indicating a potential beneficial role in Parkinson's disease by oxidative stress inhibition. Experimental and Therapeutic Medicine,2017,14:4431-4437. 3.,,. fMRI.,2017,17(1):55-58. 4.Junqi Guo,Xi Zhou,Yunchuan Sun, Gong Ping etal.Smartphone-Based Patients’ Activity Recognition by Usinga Self-Learning Scheme for Medical Monitoring.J Med Syst 2016,40:140. 5.,,... 2014; 20(12): 1105-1108. 6. 1 1,2 1..,2013,28(8):719-722..1. 7.,,.., 2007,27(9):849-850. 8.,,,. PC12.,2007,33(1):98-101. 9.,,,. PrxⅡ., 2006,26(3):338-340. 10.,,. MRI.. 2005,22(4):348-349 11.,,. MRI. 2005,22(3):260-262 12. Kangding Liu, Ping Gong,Xueling Ma,etal. Spatial expression attern of vascular endothelial growth factor and its receptor mRNA in the early stage of acute focal cerebral ischemia. 2005,9(25):201-203 13.;,.GBS MMP-9、TNF-α., 2004,4(2):85-87. 14.,,. VEGF、FLT-1、FLK-1 mRNA. 2003,20(1):38-40 15.,,. VEGF. 2003,29(3):345-346 16.,,. VEGF、VEGFR-1、2. 2003,20(4):332-333 17.,,.VEGF FLT-1、KDR/FLK-1. 2002,19(5):317-318 18.,,.VEGF VEGFR-1、VEGFR-2. 2002,22(5):402-403